COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 896: Articles 8951-8960  | Next

Detection of COVID-19 dysosmia with paired crushable odorant ampules
Wood, R. W., Stodgell, C. J., Linder, M. A., Pressman, E. K.
10.1101/2022.03.13.22271253 — Posted: 2022-03-13
Response to COVID-19 booster vaccinations in seronegative people with MS.
Tallantyre, E. C., Scurr, M. J., Vickaryous, N., Richards, A., Anderson, V., Baker, D., Chance, R., Evangelou, N., George, K., Giovannoni, G., Harding, K., Hibbert, A., Ingram, G., Jolles, S., Jones, M., Kang, A., Loveless, S., Moat, S., Robertson, N., Rios, F., Schmierer, K., Willis, M., Godkin, A., Dobson, R.
10.1101/2022.03.12.22272083 — Posted: 2022-03-13
A Hybrid Pipeline for Covid-19 Screening Incorporating Lungs Segmentation and Wavelet Based Preprocessing of Chest X-Rays
Abdulah, H., Huber, B., Abdallah, H., Palese, L. L., Soltanian-Zadeh, H., Gatti, D. L.
10.1101/2022.03.13.22272311 — Posted: 2022-03-13
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT1262b2 and after booster vaccination with BNT1262b2 or mRNA-1273: a population-based cohort study (COVIDENCE UK)
Vivaldi, G., Jolliffe, D. A., Holt, H., Tydeman, F., Talaei, M., Davies, G. A., Lyons, R. A., Griffiths, C. J., Kee, F., Sheikh, A., Shaheen, S. O., Martineau, A. R.
10.1101/2022.03.11.22272276 — Posted: 2022-03-13
Unsupervised clustering reveals phenotypes of AKI in ICU Covid19 patients
Sangla, F., Marchi, E., Assouline, B., Le Terrier, C., Sgardello, S., Pugin, J., Criton, G., Legouis, D.
10.1101/2022.03.11.22272259 — Posted: 2022-03-13
SEROLOGICAL TESTING OF BLOOD DONORS TO CHARACTERISE THE IMPACT OF COVID-19 IN MELBOURNE, AUSTRALIA, 2020
Machalek, D., Vette, K. M., Downes, M., Carlin, J. B., Nicholson, S., Hirani, R., Irving, D. O., Gosbell, I. B., Gidding, H. F., Shilling, H., Aung, E., Macartney, K., Kaldor, J. M.
10.1101/2022.03.11.22272185 — Posted: 2022-03-13
Development and Implementation of a Simple and Rapid Extraction-Free Saliva SARS-CoV-2 RT-LAMP Workflow for Workplace Surveillance
Li, Z., Bruce, J. L., Cohen, B., Cunningham, C. V., Jack, W. E., Kunin, K., Langhorst, B. W., Miller, J., Moncion, R. A., Poole, C. B., Premsrirut, P. K., Ren, G., Roberts, R. J., Tanner, N. A., Zhang, Y., Carlow, C. K. S.
10.1101/2022.03.11.22272282 — Posted: 2022-03-13
The impact of COVID-19 non-pharmaceutical interventions on future respiratory syncytial virus transmission in South Africa
Bents, S., Viboud, C., Grenfell, B., Hogan, A., Tempia, S., von Gottberg, A., Moyes, J., Walaza, S., Cohen, C., Baker, R.
10.1101/2022.03.12.22271872 — Posted: 2022-03-13
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria
Marinov, G., Mladenov, M., Rangachev, A., Alexiev, I.
10.1101/2022.03.11.22271527 — Posted: 2022-03-13
Daily Rapid Antigen Testing in a University Setting to Inform COVID-19 Isolation Duration Policy
Earnest, R., Chen, C., Chaguza, C., Grubaugh, N. D., Wilson, M. S., Yale COVID-19 Resulting and Isolation Team
10.1101/2022.03.11.22272264 — Posted: 2022-03-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).